Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Forrest

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Bioorganic & Medicinal Chemistry Letters|July 11, 2000
Discovery of an orally bioavailable alkyl oxadiazole beta3 adrenergic receptor agonistD D Feng, T Biftu, M R Candelore, et al.
Journal of Medicinal Chemistry|October 29, 2000
Discovery of a potent, orally bioavailable beta(3) adrenergic receptor agonist, (R)-N-[4-[2-[[2-hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4 -[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamideR J Mathvink, J S Tolman, D Chitty, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2000
Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective beta3 adrenergic receptor agonist antiobesity agentsT Biftu, D D Feng, G B Liang, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 1999
Human beta3 adrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamidesE M Naylor, E R Parmee, V J Colandrea, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 1999
Human beta3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamidesE R Parmee, E M Naylor, L Perkins, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profilesC C Chan, S Boyce, C Brideau, et al.
British Journal of Pharmacology|June 10, 2008
Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosteroneM J Forrest, D Bloomfield, R J Briscoe, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
3-Pyridyloxypropanolamine agonists of the beta 3 adrenergic receptor with improved pharmacokinetic propertiesA E Weber, H O Ok, R F Alvaro, et al.
The Journal of Clinical Investigation|June 17, 1998
A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeysM H Fisher, A M Amend, T J Bach, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Bioorganic & Medicinal Chemistry Letters|July 11, 2000
Discovery of an orally bioavailable alkyl oxadiazole beta3 adrenergic receptor agonistD D Feng, T Biftu, M R Candelore, et al.
Journal of Medicinal Chemistry|October 29, 2000
Discovery of a potent, orally bioavailable beta(3) adrenergic receptor agonist, (R)-N-[4-[2-[[2-hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4 -[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamideR J Mathvink, J S Tolman, D Chitty, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2000
Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective beta3 adrenergic receptor agonist antiobesity agentsT Biftu, D D Feng, G B Liang, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 1999
Human beta3 adrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamidesE M Naylor, E R Parmee, V J Colandrea, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 1999
Human beta3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamidesE R Parmee, E M Naylor, L Perkins, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profilesC C Chan, S Boyce, C Brideau, et al.
British Journal of Pharmacology|June 10, 2008
Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosteroneM J Forrest, D Bloomfield, R J Briscoe, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
3-Pyridyloxypropanolamine agonists of the beta 3 adrenergic receptor with improved pharmacokinetic propertiesA E Weber, H O Ok, R F Alvaro, et al.
The Journal of Clinical Investigation|June 17, 1998
A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeysM H Fisher, A M Amend, T J Bach, et al.
Pageof 5